Brian Dorsey, VP Product Development at Somaxon Pharmaceuticals, Inc. (SOMX), sold 76,080 shares at $9.74 ($494K) on 2010-03-18, disclosed to the SEC on 2010-03-22.
Scheduled sale ($494k) by VP Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.94 | 5,580 | $22K | 4.4% |
| 2 | $5.23 | 23,000 | $120K | 24.3% |
| 3 | $6.61 | 8,100 | $54K | 10.8% |
| 4 | $6.67 | 15,800 | $105K | 21.3% |
| 5 | $7.89 | 2,100 | $17K | 3.4% |
| 6 | $7.92 | 15,900 |
| $126K |
| 25.5% |
| 7 | $8.78 | 2,800 | $25K | 5.0% |
| 8 | $8.91 | 1,800 | $16K | 3.2% |
| 9 | $9.74 | 500 | $5K | 1.0% |
| 10 | $9.75 | 500 | $5K | 1.0% |
| Total | $6.49 avg | 76,080 | $494K | 100% |
| Filing → |
| SPRY | SELL | 2024-08-21 | $750K | — | Filing → |
| SPRY | SELL | 2024-08-15 | $390K | — | Filing → |
| APRI | BUY | 2014-12-30 | $11K | — | Filing → |